Table 1.
Colunas1 | N | % |
---|---|---|
Total women | 3,693 | 100.0 |
Pap Cytology | ||
AGC | 123 | 3.3 |
CA | 0 | 0.0 |
CC | 2 | 0.1 |
HSIL | 65 | 1.8 |
LSIL | 570 | 15.4 |
ASC | 2,933 | 79.4 |
Followed up women1 | 1,996 | 54.0 |
Loss of follow-up | 1,697 | 46.0 |
Follow up results | 1,996 | 100.0 |
Pap Cytology | ||
AGC | 87 | 4.4 |
CA | 0 | 0.0 |
CC | 2 | 0.1 |
HSIL | 48 | 2.4 |
LSIL | 303 | 15.2 |
ASC | 1,556 | 78.0 |
Progression or Regression events | ||
Non Events | 17 | 0.9 |
Events | 1,979 | 99.1 |
AGC, atypical glandular cells; CA, cervical adenocarcinoma; CC, cervical carcinoma; HSIL, high-grade squamous intraepithelial lesions; LSIL, low-grade squamous intraepithelial lesions; ASC, atypical squamous cells; 1Period of follow-up between January 2010 and July 2016.